HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 149 filers reported holding HERON THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 3.08 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $5,021,194 | -42.8% | 1,434,627 | -54.7% | 0.00% | -50.0% |
Q1 2024 | $8,773,382 | +317.2% | 3,167,286 | +156.0% | 0.00% | +300.0% |
Q4 2023 | $2,103,167 | +2562.5% | 1,237,157 | +1513.2% | 0.00% | – |
Q3 2023 | $78,993 | -27.4% | 76,692 | -18.2% | 0.00% | – |
Q2 2023 | $108,801 | +12640.2% | 93,794 | -83.4% | 0.00% | – |
Q1 2023 | $854 | -90.3% | 565,788 | -83.9% | 0.00% | -100.0% |
Q4 2022 | $8,766 | -99.9% | 3,506,354 | +108.6% | 0.01% | +25.0% |
Q3 2022 | $7,094,000 | +489.2% | 1,680,966 | +289.4% | 0.00% | – |
Q2 2022 | $1,204,000 | -82.5% | 431,638 | -64.1% | 0.00% | -100.0% |
Q1 2022 | $6,880,000 | -25.0% | 1,202,738 | +19.7% | 0.00% | -20.0% |
Q4 2021 | $9,174,000 | +80.4% | 1,004,798 | +206.6% | 0.01% | +66.7% |
Q2 2021 | $5,086,000 | -69.8% | 327,721 | -68.5% | 0.00% | -75.0% |
Q1 2021 | $16,856,000 | +298.1% | 1,039,846 | +419.8% | 0.01% | +300.0% |
Q4 2020 | $4,234,000 | +39.9% | 200,031 | -2.1% | 0.00% | -25.0% |
Q3 2020 | $3,027,000 | -49.2% | 204,238 | -59.8% | 0.00% | -69.2% |
Q1 2020 | $5,962,000 | -64.1% | 507,854 | -28.2% | 0.01% | -38.1% |
Q4 2019 | $16,627,000 | +58.5% | 707,544 | +24.8% | 0.02% | +23.5% |
Q3 2019 | $10,488,000 | +61.4% | 566,931 | +62.2% | 0.02% | +70.0% |
Q2 2019 | $6,500,000 | +311.4% | 349,629 | +440.8% | 0.01% | +400.0% |
Q1 2019 | $1,580,000 | +20.2% | 64,650 | +55.7% | 0.00% | 0.0% |
Q3 2018 | $1,315,000 | -81.1% | 41,535 | -76.8% | 0.00% | -77.8% |
Q2 2018 | $6,968,000 | +22.1% | 179,364 | -43.1% | 0.01% | +12.5% |
Q4 2017 | $5,705,000 | -4.5% | 315,173 | -14.8% | 0.01% | -11.1% |
Q3 2017 | $5,973,000 | +155.5% | 369,874 | +119.1% | 0.01% | +125.0% |
Q2 2017 | $2,338,000 | -30.6% | 168,777 | -34.3% | 0.00% | -42.9% |
Q4 2016 | $3,368,000 | -11.3% | 257,062 | +28.5% | 0.01% | -22.2% |
Q1 2016 | $3,798,000 | -84.0% | 200,000 | -73.7% | 0.01% | -80.0% |
Q2 2015 | $23,686,000 | +140.8% | 760,146 | +12.4% | 0.04% | +150.0% |
Q1 2015 | $9,838,000 | +293.8% | 676,152 | +172.3% | 0.02% | +260.0% |
Q4 2014 | $2,498,000 | +49.6% | 248,357 | +23.9% | 0.01% | +25.0% |
Q3 2014 | $1,670,000 | -36.4% | 200,469 | -5.9% | 0.00% | -42.9% |
Q2 2014 | $2,624,000 | +9.2% | 213,006 | +23.3% | 0.01% | 0.0% |
Q1 2014 | $2,402,000 | – | 172,697 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Velan Capital Investment Management LP | 6,986,744 | $24,453,604 | 14.01% |
Tejara Capital Ltd | 4,187,860 | $14,657,510 | 5.33% |
JW Asset Management, LLC | 2,292,418 | $8,023,463 | 3.31% |
Richmond Brothers, Inc. | 356,558 | $1,247,954 | 2.47% |
Rubric Capital Management LP | 26,713,503 | $93,497,261 | 2.45% |
Orchard Capital Management, LLC | 2,243,426 | $7,851,991 | 2.37% |
Congress Park Capital LLC | 1,578,501 | $5,524,754 | 2.22% |
CM Management, LLC | 300,000 | $1,050,000 | 0.96% |
Monaco Asset Management SAM | 1,513,164 | $5,296,074 | 0.84% |
TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $6,475,000 | 0.66% |